Dishman Pharmaceuticals & Chemicals IPO GMP History
Dishman Pharmaceuticals & Chemicals IPO has been listed on April 22, 2004 at a listing price of ₹345, against the issue price of ₹175 — a gain of ₹170 (+97.14%). The day-wise GMP trend below shows how grey market sentiment evolved from subscription to listing.
Dishman Pharmaceuticals & Chemicals IPO raised ₹60.09 Cr. through its IPO at a price band of ₹155 to ₹175 per share, with a lot size of 50 shares. The IPO was open for subscription from 29 Mar 2004 to 07 Apr 2004.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
GMP trend
Grey market premium sampled three times a day (11 AM, 5 PM, 10 PM). Last updated 12 Nov, 8:58 PM IST.
Day-wise GMP
The last reading of each day, newest first. Arrows compare with the previous day.
| Date | GMP | ↑↓ | % | Kostak | Sub. Sauda |
|---|---|---|---|---|---|
| No GMP history available yet. | |||||
Dishman Pharmaceuticals & Chemicals IPO dates
Key dates from opening to listing. Today is 12 November.
- Open 29 Mar 2004
- Close 07 Apr 2004
- Allotment TBA
- Refund/credit TBA
- Listing 22 Apr 2004
Dishman Pharmaceuticals & Chemicals IPO actual listing price
How the grey market's final call compared with the listing-day open.
| Issue price | ₹175 |
|---|---|
| Listing gain / loss | +₹170 per share |
| Listing date | 22 Apr, 2004 |
| Actual listing price | ₹345 (+97.14%) |
Is Dishman Pharmaceuticals & Chemicals IPO GMP reliable?
Grey market premium for Dishman Pharmaceuticals & Chemicals IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:
- 01Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
- 02Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
- 03Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
- 04Cross-check before acting: Review the Dishman Pharmaceuticals & Chemicals IPO full review for a fundamentals-based assessment before making any grey market trades.
Dishman Pharmaceuticals & Chemicals IPO Kostak rate explained
Two ways the grey market trades an IPO application before listing.
The Kostak rate for Dishman Pharmaceuticals & Chemicals IPO was not available during the subscription period. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.
The Subject to Sauda price was not available for this IPO. Subject to Sauda only applies if allotment is confirmed — the buyer pays a premium on top of the issue price per lot allotted.
Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.
About Dishman Pharmaceuticals & Chemicals IPO
Dishman Pharmaceuticals and Chemicals Limited was incorporated on 29 June 1983 as a private limited company. Its promoter is Janmejay R. Vyas.
It makes QUATs (phase transfer catalysts), specialty chemicals, intermediates and APIs, and offers contract manufacturing and research, from facilities at Bavla and Naroda in Gujarat.
The prospectus said no other listed company in India made QUATs. It had subsidiaries in Europe, including Dishman Europe, set up in 1997.
The IPO was Rs 60.09 crore and was entirely a fresh issue at Rs 175, the top of the Rs 155 to Rs 175 band. The money was for a GMP API plant, an intermediate plant, a research centre and expansion.
Frequently asked
What is the GMP of Dishman Pharmaceuticals & Chemicals IPO?
The current Grey Market Premium (GMP) of Dishman Pharmaceuticals & Chemicals IPO is not yet started or active in the market.
What is the Kostak Price of Dishman Pharmaceuticals & Chemicals IPO?
Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Dishman Pharmaceuticals & Chemicals IPO is not available.
What is the Subject to Sauda Price of Dishman Pharmaceuticals & Chemicals IPO?
Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is not available.
What was the actual listing price of Dishman Pharmaceuticals & Chemicals IPO?
Dishman Pharmaceuticals & Chemicals IPO listed on April 22, 2004 at ₹345, against the issue price of ₹175 — a gain of +97.14%.
How did the GMP of Dishman Pharmaceuticals & Chemicals IPO trend before listing?
The GMP of Dishman Pharmaceuticals & Chemicals IPO was stable in its final days before listing. View the day-wise table above for the complete GMP history.
Explore Dishman Pharmaceuticals & Chemicals IPO further
The grey market is one signal. Read it alongside the demand, the reviews and the filings before you decide.
It has listed — go back to the fundamentals.
Category-wise demand from QIB, NII and retail investors, updated through the day.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
The grey market called it. Now check the fundamentals.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Read the grey market alongside the subscription book and the offer document before you apply.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.
